Insider Selling: NEXGEL, Inc. (NASDAQ:NXGL) Director Sells 3,000 Shares of Stock

NEXGEL, Inc. (NASDAQ:NXGL) Director Scott Robert Henry sold 3,000 shares of the firm’s stock in a transaction that occurred on Tuesday, January 7th. The shares were sold at an average price of $3.37, for a total transaction of $10,110.00. Following the completion of the transaction, the director now owns 141,553 shares of the company’s stock, valued at approximately $477,033.61. This trade represents a 2.08 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Scott Robert Henry also recently made the following trade(s):

• On Friday, December 20th, Scott Robert Henry sold 3,000 shares of NEXGEL stock. The stock was sold at an average price of $4.64, for a total transaction of $13,920.00.

NEXGEL Price Performance

NXGL stock opened at $3.43 on Friday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.93 and a current ratio of 1.51. NEXGEL, Inc. has a 52-week low of $1.84 and a 52-week high of $5.10. The company has a market capitalization of $23.29 million, a P/E ratio of -5.91 and a beta of 0.61. The company has a fifty day moving average price of $3.72 and a 200-day moving average price of $3.01.

Institutional Inflows and Outflows

An institutional investor recently raised its position in NEXGEL stock. Northeast Financial Group Inc. lifted its stake in shares of NEXGEL, Inc. (NASDAQ:NXGL) by 168.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 31,848 shares of the company’s stock after acquiring an additional 20,000 shares during the quarter. Northeast Financial Group Inc. owned approximately 0.50% of NEXGEL worth $82,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 2.21% of the company’s stock.

About NEXGEL

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.